The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 09, 2021
Filed:
Jan. 06, 2020
Applicant:
Azienda Ospedaliera Universitaria Senese, Siena, IT;
Inventors:
Andreas Meyerhans, Barcelona, ES;
Miguel Angel Martinez De La Sierra, Vilassar de Mar Barcelona, ES;
Annalaura Brai, Siena, IT;
Roberta Fazi, Siena, IT;
Cristina Tintori, Siena, IT;
Maurizio Botta, Siena, IT;
Jose Este-Araque, Tiana Barcelona, ES;
Javier Martinez, Barcelona, ES;
Assignee:
AZIENDA OSPEDALIERA UNIVERSITARIA SENESE, Siena, IT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4192 (2006.01); A61K 31/4245 (2006.01); A61K 31/433 (2006.01); A61K 31/4439 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/675 (2006.01); C07D 249/06 (2006.01); C07F 9/6518 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 261/08 (2006.01); C07D 271/06 (2006.01); C07D 271/10 (2006.01); C07D 285/12 (2006.01); C07D 249/04 (2006.01); C07D 257/04 (2006.01); A61K 31/42 (2006.01); A61K 31/7056 (2006.01); A61K 45/06 (2006.01); C07D 401/04 (2006.01); C07H 15/18 (2006.01);
U.S. Cl.
CPC ...
C07D 249/06 (2013.01); A61K 31/4192 (2013.01); A61K 31/42 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/675 (2013.01); A61K 31/7056 (2013.01); A61K 45/06 (2013.01); C07D 249/04 (2013.01); C07D 257/04 (2013.01); C07D 261/08 (2013.01); C07D 271/06 (2013.01); C07D 271/10 (2013.01); C07D 285/12 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07F 9/6518 (2013.01); C07H 15/18 (2013.01);
Abstract
The present invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity of formula I and II and their therapeutic use, in particular for the treatment of viral diseases.